Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome;Impacto da vacinação contra rubéola na ocorrência da síndrome da rubéola congênita

Jornal de Pediatria

Volumn 83, Issue 5, 2007, Pages 415-421

  Lanzieri, Tatiana Miranda ^a   Pinto, Diana ^b   Prevots, D Rebecca ^c  

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b Secretaria da Indústria e Comércio do Estado da Paraíba   (Brazil)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Brazil; Congenital rubella syndrome; Outbreaks; Rubella; Vaccination

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CLINICAL STUDY; CONFIDENCE INTERVAL; CONGENITAL RUBELLA SYNDROME; DATA COLLECTION METHOD; ENZYME IMMUNOASSAY; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; IMMUNIZATION; INCIDENCE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PREGNANCY; RUBELLA;

EID: 35349031255     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1692     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention (CDC). Rubella prevention. MMWR Morb Mortal Wkly Rep. 1984;33:301-10; 315-8.
2. Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ. 1997;75: 55-68.
3. Lanzieri TM, Segatto TC, Siqueira MM, de Oliveira Santos EC, Jin L, Prevots DR. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001. Pediatr Infect Dis J. 2003;22: 323-9.
4. Lanzieri TM, Prevots DR, Dourado I. Surveillance of congenital rubella syndrome in Brazil, 1995-2005. J Pediatr Infect Dis. 2007;2:15-22.
5. Prevots DR, Parise MS, Segatto TC, Siqueira MM, dos Santos ED, Ganter B, et al. Interruption of measles transmission in Brazil, 2000-2001. J Infect Dis. 2003;187 Suppl 1:S111-20.
6. Accelerated control of rubella and prevention of congenital rubella syndrome, Brazil. Wkly Epidemiol Rec. 2002;77:169-75.
7. Pan American Health Organization (PAHO). 44th Directing Council. Resolution CD44.R1: sustaining immunization programs - elimination of rubella and congenital rubella syndrome (CRS). 2003. http://www.paho.org/English/GOV/CD/ cd44-fr-e.pdf. Acesso: 17/03/2007.
8. World Health Organization. Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs. Geneva: WHO; 2000.
9. Reef SE, Plotkin S, Cordero JF, Katz M, Cooper L, Schwartz B, et al. Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis. 2000;31: 85-95.
10. Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol. 1993;77: 358-63.
11. Peckham C. Congenital rubella in the United Kingdom before 1970: the prevaccine era. Rev Infect Dis. 1985;7 Suppl 1:S 11-6.
12. Lanzieri TM, Parise MS, Siqueira MM, Fortaleza BM, Segatto TC, Prevots DR. Incidence, clinical features and estimated costs of congenital rubella syndrome after a large rubella outbreak in Recife, Brazil, 1999-2000. Pediatr Infect Dis J. 2004;23: 1116-22.
13. Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital rubella syndrome global update. Rev Pan Am Salud Publica. 2003;14: 306-15.
14. Schatzmayr HG. Aspects of rubella infection in Brazil. Rev Infect Dis. 1985;7 Suppl 1:S 53-5.
15. De Azevedo Neto RS, Silveira AS, Nokes DJ, Yang HM, Passos SD, Cardoso MR, et al. Rubella seroepidemiology in a nonimmunized population of Sao Paulo State, Brazil. Epidemiol Infect. 1994;113:161-73.
16. Halloran ME, Haber M, Longini IM, Struchiner CJ. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol. 1991;133: 323-31.
17. Accelerated control of rubella and prevention of congenital rubella syndrome, Brazil. Wkly Epidemiol Rec. 2002;77:169-75.
18. Bart KJ, Orenstein WA, Preblud SR, Hinman AR, Lewis FL, Williams NM. Elimination of rubella and congenital rubella from the United States. Pediatr Infect Dis. 1985;4: 14-21.
19. Centers for Disease Control and Prevention (CDC). Nationwide campaign for vaccination of adults against rubella and measles - Costa Rica, 2001. MMWR Morb Mortal Wkly Rep. 2001; 50:976-9.
20. Chile, Ministry of Health, Division de salud de las personas, Departamento de epidemiologia. La campana de vacunación contra la rubéola en Chile. Santiago: Ministry of Health; 2000.
21. Irons B, Lewis MJ, Dahl-Regis M, Castillo-Solórzano C, Carrasco PA, de Quadros CA. Strategies to eradicate rubella in the English speaking Caribbean. Am J Public Health. 2000;90:1545-9.
22. Pan American Health Organization (PAHO). Rubella vaccination of women of childbearing age in the Americas. EPI Newsletter. 2001;23:6.
23. Vynnycky E, Gay NJ, Cutts FT. The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome. Vaccine. 2003;21: 2708-19.